Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Afonina

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 2, 2011
In-use stability modelingRobert T Magari, Elena Afonina
Reumatologia Clinica|June 23, 2018
Scleroderma "en coup de sabre" With Epilepsy and Uveitis Successfully Treated With TocilizumabMaria Osminina, Nathalia Geppe, Elena Afonina
STAR Protocols|July 19, 2022
Isolation of tumor-infiltrating lymphocytes from preserved human tumor tissue specimens for downstream characterizationTamiyo Kobayashi, Shogo Kumagai, Rieko Doi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear exportDirk Daelemans, Elena Afonina, Jakob Nilsson, et al.
Journal of Molecular Biology|March 5, 2003
Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparumOluwatoyin A Asojo, Sergei V Gulnik, Elena Afonina, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Enamino-oxindole HIV protease inhibitorsMichael Eissenstat, Tanya Guerassina, Sergei Gulnik, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 28, 2002
Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370Oluwatoyin A Asojo, Elena Afonina, Sergei V Gulnik, et al.
World Journal of Clinical Pediatrics|June 1, 2026
Use of nailfold capillaroscopy for evaluation of disease activity in juvenile dermatomyositis: Results of a two-center retrospective studyVera Podzolkova, Ilia S Avrusin, Maria Nikolaeva, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|August 2, 2011
In-use stability modelingRobert T Magari, Elena Afonina
Reumatologia Clinica|June 23, 2018
Scleroderma "en coup de sabre" With Epilepsy and Uveitis Successfully Treated With TocilizumabMaria Osminina, Nathalia Geppe, Elena Afonina
STAR Protocols|July 19, 2022
Isolation of tumor-infiltrating lymphocytes from preserved human tumor tissue specimens for downstream characterizationTamiyo Kobayashi, Shogo Kumagai, Rieko Doi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear exportDirk Daelemans, Elena Afonina, Jakob Nilsson, et al.
Journal of Molecular Biology|March 5, 2003
Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparumOluwatoyin A Asojo, Sergei V Gulnik, Elena Afonina, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Enamino-oxindole HIV protease inhibitorsMichael Eissenstat, Tanya Guerassina, Sergei Gulnik, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 28, 2002
Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370Oluwatoyin A Asojo, Elena Afonina, Sergei V Gulnik, et al.
World Journal of Clinical Pediatrics|June 1, 2026
Use of nailfold capillaroscopy for evaluation of disease activity in juvenile dermatomyositis: Results of a two-center retrospective studyVera Podzolkova, Ilia S Avrusin, Maria Nikolaeva, et al.
Pageof 1